TrialJournal of clinical psychopharmacology

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials.

Lenard A Adler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.